Results 1 to 10 of about 64,761 (239)

Aspergillosis: An Update on Epidemiology, Risk Factors, Diagnosis, Susceptibility, and Treatment [PDF]

Journal of Fungi
Aspergillosis is one of the most common fungal infections worldwide, caused by various species belonging to the genus Aspergillus, affecting both immunocompetent and immunocompromised individuals.
Carlos Alberto Castro-Fuentes, Juan Pablo Cabrera-Guerrero, Esperanza Duarte-Escalante, Graciela Hernández Silva, Alberto Chinney Herrera, María del Rocío Reyes-Montes   +5 more
doaj   +2 more sources

Invasive pulmonary aspergillosis in critically ill patients with pneumonia due to COVID-19, influenza, and communityacquired pneumonia: A prospective observational study [PDF]

Current Medical Mycology, 2022
Background and Purpose: Influenza A and SARS-CoV-2 are risk factors for invasive pulmonary aspergillosis. Both influenza-associated pulmonary aspergillosis and COVID-19-associated pulmonary aspergillosis result in high mortality and poor clinical ...
Ahsan Syed, Kausar Jabeen, Joveria Farooqi, Hammad Niamatullah, Aisha Fareed Siddiqui, Safia Awan, Alishah Akbar, Irfan Muhammad   +7 more
doaj   +1 more source

Therapeutic effects of Rheumatoid Arthritis on Aspergillosis development [PDF]

Reviews in Clinical Medicine, 2020
Aspergillosis is a common fungal infection with systemic characteristics, which is caused by various species of Aspergillus. The infection could develop in immunocompromised and immunocompetent patients under specific circumstances. Based on the clinical
Ali AL-Janabi
doaj   +1 more source

Invasive sinus aspergillosis with mycotic aneurysm of the vertebral artery and subarachnoid hemorrhage – Case report

Radiology Case Reports, 2021
Invasive sinus aspergillosis is a rare life-threatening condition usually found in immunocompromised patients. The fungus spreads from paranasal sinuses into the central nervous system by direct extension or through blood vessels. Perineural spread is an
Maruša Mencinger, MD, Tadeja Matos, Asst. Prof., MD PhD, Katarina Šurlan Popović, Assoc. Prof., MD PhD   +2 more
doaj   +1 more source

Risk factors for relapse of chronic pulmonary aspergillosis after discontinuation of antifungal therapy

Clinical Infection in Practice, 2020
Objectives: We aimed to identify the frequency and risk factors for disease relapse following cessation of antifungal therapy in CPA. Methods: This retrospective audit at the National Aspergillosis Centre, Manchester, UK assessed outcomes for patients ...
Felix Bongomin, Akaninyene Otu, Chris Harris, Philip Foden, Chris Kosmidis, David W. Denning   +5 more
doaj   +1 more source

Pulmonary Aspergillosis [PDF]

Seminars in Respiratory and Critical Care Medicine, 2008
As the population of patients with prolonged neutropenia, those receiving hematopoietic stem cell transplantation or lung transplantation, or those with human immunodeficiency virus or acquired immunodeficiency syndrome continues to increase, the rising incidence of pulmonary aspergillosis is unlikely to diminish.
George R, Thompson, Thomas F, Patterson
openaire   +2 more sources

Pleuropulmonary aspergillosis in an immunocompetent patient presenting as pleural-based peripheral lung mass: A sporadic occurrence

Journal of Association of Pulmonologist of Tamil Nadu, 2021
The importance of knowledge about pulmonary aspergillosis has increased immensely in the era of COVID-19 as a significant number of post-COVID patients develop lung infection with aspergillosis, an entity called COVID-associated pulmonary aspergillosis ...
P Amal Johnson, R Narasimhan, Ajay Narasimhan   +2 more
doaj   +1 more source

Late-onset isavuconazole-induced liver injury

Medical Mycology Case Reports, 2018
Antifungal agents account for approximately 3% of Drug-Induced Liver Injury (DILI) cases. Isavuconazole is a novel triazole, and experience with long-term use of it is lacking.
Felix Bongomin, Isabel Rodriguez-Goncer, Carol Lorden, Akaninyene Otu, Rohit Bazaz   +4 more
doaj   +1 more source

Successful long-term terbinafine therapy in an asthmatic patient with Aspergillus sensitization and bronchiectasis

Medical Mycology Case Reports, 2017
Severe asthma with fungal sensitization (SAFS) is estimated to affect ~25% of patients with poorly controlled asthma. Tri-azole therapy is effective in only 60–80% and side effects are common.
Isabel Rodriguez-Goncer, Rob Niven, David W. Denning   +2 more
doaj   +1 more source

Nebulised N-Acetylcysteine for Unresponsive Bronchial Obstruction in Allergic Brochopulmonary Aspergillosis: A Case Series and Review of the Literature

Journal of Fungi, 2018
Many chronic lung diseases are characterized by the hypersecretion of mucus. In these conditions, the administration of mucoactive agents is often indicated as adjuvant therapy. N-acetylcysteine (NAC) is a typical example of a mucolytic agent.
Akaninyene Otu, Philip Langridge, David W. Denning   +2 more
doaj   +1 more source